Concepedia

Sam Hariry

SH

7

Publications

591

Citations

7

H-Index

2010

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Sam Hariry is an author at Novartis (Switzerland) specializing in medicine, pharmacotherapy, and physiology.

Top concepts

Publications per year

2010–2017

7

Publications

7

Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study

Daniel Rooks, Jens Præstgaard, Sam Hariry et al. · Journal of the American Geriatrics Society · 2017 · 215 citations

AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials

Daniela Berg, Jana Godau, Claudia Trenkwalder et al. · Movement Disorders · 2011 · 172 citations

Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects

Sam Rebello, Sally Zhao, Sam Hariry et al. · European Journal of Clinical Pharmacology · 2011 · 66 citations

, , +6

Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks

Baltazar Gomez‐Mancilla, Ronald Brand, Tim Jürgens et al. · Cephalalgia · 2013 · 43 citations · Full text

Placebo-controlled study of the effects of fingolimod on cardiac rate and rhythm and pulmonary function in healthy volunteers

Robert Schmouder, Sam Hariry, Olivier David · European Journal of Clinical Pharmacology · 2011 · 41 citations

, , +9

Rows per page

1–5 of 7